Company Filing History:
Years Active: 2010-2012
Title: Evelyne Chaput: Innovator in HDL-Cholesterol Raising Agents
Introduction
Evelyne Chaput is a notable inventor based in Sierentz, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that raise HDL cholesterol levels. With a total of 2 patents to her name, her work has the potential to impact cardiovascular health positively.
Latest Patents
Evelyne Chaput's latest patents include innovative methods for raising HDL cholesterol. The first patent focuses on pyrazinecarboxamide derivatives as HDL-cholesterol raising agents. This invention relates to a method of raising HDL cholesterol by administering a specific compound to patients in need. The second patent involves 3-pyridinecarboxamide derivatives, which also serve as HDL-cholesterol raising agents, following a similar methodology.
Career Highlights
Throughout her career, Evelyne has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. Her experience in these organizations has allowed her to develop her expertise in drug formulation and innovation.
Collaborations
Evelyne has collaborated with several professionals in her field, including Mirjana Andjelkovic and Agnes Benardeau. These collaborations have contributed to her research and development efforts, enhancing the impact of her inventions.
Conclusion
Evelyne Chaput is a pioneering inventor whose work in HDL-cholesterol raising agents showcases her commitment to improving health outcomes. Her patents reflect her innovative spirit and dedication to advancing pharmaceutical science.